5a ) and about 5.7 fold higher risk of distant metastases (HR 5.70, CI 1.26 - 10.73, p = 0.017, data not shown), although it did not reach statistical significance in terms of OS rates (4-years OS 83% vs. 88%, p = 0.075, Table 4 and Fig. 5c ; HR=2.821, CI 0.72 - 11.11, p = 0.138, data not presented).
← all excerpts
Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer.
1
0.0750
0.0750